Breast Cancer Awareness Month: Gene Solutions Indonesia and Garuda Sentra Medika Amplify Early Cancer Detection Education

Gene Solutions Indonesia received commemorative plaque from Garuda Sentra Medika
Gene Solutions Indonesia received commemorative plaque from Garuda Sentra Medika

This October, as the world turns its attention to breast cancer awareness, Gene Solutions Indonesia and Garuda Sentra Medika united to promote a powerful message: the importance of early cancer detection. On October 29, 2024, we hosted an inspiring event dedicated to empowering individuals with essential knowledge on early detection, particularly for breast cancer—one of the most pressing health concerns worldwide.

Dr. dr. Andhika Rahman, SpPD-KHOM Introduce MCED
Dr. dr. Andhika Rahman, SpPD-KHOM Introduce MCED
Gene Solutions Indonesia Introduce SPOT-MAS
Gene Solutions Indonesia Introduce SPOT-MAS

In the warm glow of the event space, a renowned oncologist Dr. Andhika Rahman, SpPD-KHOM, led participants through an insightful session on Multi-Cancer Early Detection (MCED). Dr. Andhika shared not only the science but the hope behind MCED—a method that can identify cancer in its earliest stages, when it’s most treatable, offering a real opportunity for positive outcomes. His message reminded us all of the profound impact that early detection can have in saving lives.

Interactive Quiz Session
Interactive Quiz Session

Throughout the day, participants had the chance to explore hands-on activities and join in lively discussions, experiencing firsthand how accessible and transformative early detection can be. Complex ideas were made easy to understand, bringing everyone together around the importance of staying informed and vigilant about their health.

We extend our heartfelt thanks to all who joined us in this journey of raising awareness. Together, we hope to inspire proactive health choices and demonstrate that the path to a healthier future starts with understanding, awareness, and early action.

To continue this journey, we invite you to watch our video on breast cancer awareness and early detection: https://www.youtube.com/watch?v=NcAflYI49jE&t=34s

About Gene Solutions Indonesia:

Established in 2022, PT Gene Solutions Indonesia has been diligently advancing genetic testing and providing essential support to healthcare practitioners. We recognize the significance of Next-Generation Sequencing (NGS) in prenatal care and molecular diagnostics. Through our valued partnership with KALGen INNOLAB, we strive to make Non-Invasive Prenatal Testing (NIPT) and oncology diagnostics accessible to the Indonesian population.

Follow Gene Solutions Indonesia on Instagram to get latest update. https://www.instagram.com/genesolutions.id/

LATEST News

New Study Validates Gene Solutions’ Upgraded ctDNA Workflow Behind K-TRACK and K-4CARE

New Study Validates Gene Solutions’ Upgraded ctDNA Workflow Behind K-TRACK and K-4CARE

Peer-reviewed findings published in The Journal of Liquid Biopsy, an official journal of the International Society of Liquid Biopsy (ISLB), demonstrate broader ctDNA analysis, improved recurrence prediction, and greater flexibility with or without tumor tissue. SINGAPORE, 14 October 2026 – Gene Solutions announced the publication of a new peer-reviewed study validating the upgraded ctDNA workflow behind K-TRACK, K-4CARE, and K-TRACK Blood Only. Published in The Journal of Liquid Biopsy, an official journal of the International Society of Liquid Biopsy (ISLB), the study evaluated how Gene Solutions’ new hybrid-capture sequencing workflow and VarSURE bioinformatics pipeline improve upon its previous amplicon-based ctDNA method.

Read More

Biomarker and ctDNA Testing: A Personalized Approach to Cancer Care

Cancer diagnosis often brings many questions: Which treatment is most suitable for me? Is my treatment working? Has cancer changed? Could it come back? Every person’s cancer is different. Even when two people have the same type of cancer, their tumors may have different biological features. These differences can influence how the cancer behaves and how it responds to treatment. Biomarker and circulating tumor DNA, or ctDNA, testing may help doctors better understand these differences. Together, these tests may support more personalized treatment decisions and provide additional information as the cancer changes over time. Why can the same cancer respond

Read More
Gene Solutions NIPT preterm birth prenatal health

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth, pointing to a potential path toward earlier pregnancy-risk assessment. SINGAPORE, Sept. 25, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics and artificial intelligence to improve pregnancy care, cancer detection and precision medicine, today announced the publication of a study showing the potential to assess the risk of spontaneous preterm birth from cell-free DNA fragmentomic signals already present in routine first-trimester non-invasive prenatal testing (NIPT) data. Published in AJOG Global Reports, the

Read More